ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

NIH Cool On OIG, But the Awardees Love it, DeVita Says

October 17, 1986

International Group Plans Survey On Thrombosis Risk

July 27, 2001

DePinho Apologizes For Investment Advice: On CNBC He Recommended A Firm He Founded

June 1, 2012

Review Of DCCR Programs Uncovers Problems, Assigns Scores To Each

June 30, 1978

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

DCPC Board Approves “Working” Guidelines For Early Detection

October 2, 1987